School of Medicine
Showing 261-270 of 1,552 Results
-
Nymisha Chilukuri, MD
Clinical Assistant Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsMy research interests are to use clinical informatics to improve access to equitable care for children in under-served communities. My main areas of research interest currently include optimizing clinical informatics solutions for those with non-English preferred languages and improving interoperability between health systems, public health and community partners for pediatric patients and families.
-
Ritu Chitkara
Clinical Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsSimulation based research, Neonatal Resuscitation research
-
Mildred Cho, PhD
Professor (Research) of Pediatrics (Center for Biomedical Ethics) and of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsDr. Cho's major areas of interest include: ethical and social issues in genetic research, including those arising from gene therapy and editing, synthetic biology, microbiome research, the use of artificial intelligence to analyze genomic and medical data, the effects of gene patenting on clinical genetic testing and research, and the impacts of academic-industry ties on biomedical research.
-
Valerie Chock
Professor of Pediatrics (Neonatology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine)
Current Research and Scholarly InterestsNeurological monitoring in critically ill infants. Altered hemodynamics in neonates, especially in relation to prematurity, congenital heart disease, and central nervous system injury. Determination of the hemodynamic significance and effects of a patent ductus arteriosus in the preterm infant. Utilizing NIRS (near-infrared spectroscopy) and other technologies for improved monitoring in the NICU.
-
Ricky Y. Choi, MD, MPH
Clinical Assistant Professor, Pediatrics - General Pediatrics
BioRicky Y. Choi, MD, MPH is Clinical Assistant Professor at the Stanford University School of Medicine in the Division of General Pediatrics where he attends on the newborn nursery service and in outpatient clinic. He also leads digital health initiatives for the Division. In the past he has served in a number of clinical leadership positions including as the Department Head of Pediatrics at Asian Health Services Community Health Center in Oakland, CA. He has held multiple national physician leadership roles for many years including the Board of Directors for the National Physicians Alliance and as the founding Chair of the Immigrant Child Health Group of the American Academy of Pediatrics. He is a past Fellow of the California HealthCare Foundation Health Care Leadership Program.
In addition to his clinical work, Dr. Choi serves as the Head of Digital Health at Samsung Electronics America where he leads virtual care, strategy and strategic partnerships. Initially based out of Samsung's headquarters in South Korea and now in the Bay Area, Dr. Choi's expertise is in delivering improved clinical and financial outcomes by using consumer technologies to drive health engagement. -
Danny Hung-Chieh Chou
Associate Professor of Pediatrics (Endocrinology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur research program integrates concepts of chemical biology, protein engineering and structure biology to design new therapeutic leads and generate probes to study biological processes. A key focus of our lab is insulin, an essential hormone in our body to reduce blood glucose levels. We generate synthetic libraries of insulin analogs to select for chemical probes, and investigate natural insulin molecules (e.g. from the venom of fish-hunting cone snails!) to develop novel therapeutic candidates. We are especially interested in using chemical and enzymatic synthesis to create novel chemical entities with enhanced properties, and leverage the strong expertise of our collaborators to apply our skill sets in the fields of cancer biology, immunology and pain research. Our ultimate goal is to translate our discovery into therapeutic interventions in human diseases.
